ClearPoint Neuro, Inc. — Director's Dealing 2023

Mar 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2023-03-06

Reporting Person: SABRA MAZIN (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-06	Stock Options (right to buy)	$8.1	A	11522	Acquired	2033-03-06	Common Stock (11522.0)	Direct
2023-03-06	Restricted Stock Units	$	A	34567	Acquired		Common Stock (34567.0)	Direct

Footnotes

F1: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

F2: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

F3: The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.